marketcaparena
Search

    UHS

    UNIVERSAL HEALTH SERVICES INC

    Company overview

    Market capitalization
    $10.46B
    Employees
    101,500
    Latest publication
    2026-09-29
    About UNIVERSAL HEALTH SERVICES INC

    Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20232023-09-30 · USDQ1 20232023-03-31 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USDQ1 20212021-03-31 · USDQ4 20202020-12-31 · USD
    Total Revenue4,638,012,000USD4,486,048,000USD3,562,774,000USD3,467,518,000USD3,155,999,000USD3,197,880,000USD3,012,987,000USD3,086,935,000USD
    Other Operating Expenses1,351,958,000USD———————
    Total Operating Expenses4,121,337,000USD3,546,056,000USD2,898,750,000USD2,808,829,000USD2,473,357,000USD2,420,879,000USD2,370,208,000USD2,321,652,000USD
    Operating Income516,675,000USD517,232,000USD285,357,000USD278,700,000USD314,808,000USD438,968,000USD295,669,000USD413,959,000USD
    Total Other Income Expense Net-37,549,000USD64,210,000USD-64,850,000USD-64,599,000USD-27,918,000USD-12,170,000USD-22,792,000USD-11,581,000USD
    Interest Expense39,912,000USD42,464,000USD53,378,000USD50,876,000USD20,278,000USD21,709,000USD22,026,000USD21,823,000USD
    Labor And Related Expense2,140,309,000USD———————
    Income Before Tax479,126,000USD581,442,000USD220,507,000USD214,101,000USD286,890,000USD426,798,000USD272,877,000USD402,378,000USD
    Income Tax Expense114,536,000USD133,604,999USD52,499,000USD51,726,000USD67,515,000USD101,522,000USD63,807,000USD94,644,000USD
    Net Income364,590,000USD445,941,000USD166,989,000USD163,115,000USD217,955,000USD324,363,000USD208,539,000USD307,714,000USD
    Minority Interest6,143,000USD-1,896,000USD-1,019,000USD740,000USD-1,024,000USD96,673,000USD-21,000USD-974,000USD
    Net Income Applicable To Common Shares358,447,000USD445,941,000USD166,937,000USD162,986,000USD217,955,000USD324,363,000USD209,091,000USD308,708,000USD
    Cost Of Revenue—422,760,000USD378,667,000USD379,989,000USD367,834,000USD338,033,000USD347,110,000USD351,324,000USD
    Gross Profit—4,063,288,000USD3,184,107,000USD3,087,529,000USD2,788,165,000USD2,859,847,000USD2,665,877,000USD2,735,611,000USD
    Selling General Administrative—2,085,515,000USD1,820,336,000USD1,788,257,000USD1,584,823,000USD1,517,084,000USD1,529,097,000USD1,497,162,000USD
    Unclassified Operating Expenses—1,460,541,000USD1,078,414,000USD1,020,572,000USD888,534,000USD903,795,000USD841,111,000USD824,490,000USD
    Interest Income—247,000USD53,378,000USD50,876,000USD21,199,000USD21,299,000USD904,000USD1,937,000USD
    Net Interest Income—-42,217,000USD-53,378,000USD-50,876,000USD-21,199,000USD-21,299,000USD-21,957,000USD-19,886,000USD
    Tax Provision—133,605,000USD52,499,000USD51,726,000USD67,515,000USD101,522,000USD63,807,000USD94,644,000USD
    Net Income From Continuing Ops—447,837,000USD168,008,000USD162,375,000USD219,375,000USD325,276,000USD209,070,000USD307,734,000USD
    Ebit—622,655,000USD272,731,000USD263,849,000USD307,168,000USD447,481,000USD294,646,000USD423,128,000USD
    Ebitda—785,989,000USD409,926,000USD405,470,000USD441,630,000USD581,466,000USD426,049,000USD557,058,000USD
    Depreciation And Amortization—163,334,000USD137,195,000USD141,621,000USD134,462,000USD133,985,000USD131,403,000USD133,930,000USD
    Reconciled Depreciation—163,334,000USD137,195,000USD141,621,000USD134,462,000USD133,985,000USD131,403,000USD133,930,000USD
    Non Operating Income Net Other———-13,723,000USD-6,719,000USD9,129,000USD-835,000USD8,305,000USD
    Source0001193125-26-340278DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20232023-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20072007-12-31 · USDFY 20062006-12-31 · USDFY 20042004-12-31 · USDFY 20032003-12-31 · USDFY 20022002-12-31 · USD
    Total Revenue14,281,976,000USD12,642,117,000USD11,558,897,000USD4,751,005,000USD4,191,300,000USD3,938,320,000USD3,643,566,000USD3,258,898,000USD
    Cost Of Revenue1,532,828,000USD1,427,134,000USD1,288,132,000USD666,320,000USD547,915,000USD1,953,622,000USD1,119,227,000USD1,212,550,000USD
    Gross Profit12,749,148,000USD11,214,983,000USD10,270,765,000USD4,016,830,000USD3,576,777,000USD1,683,868,000USD2,518,263,000USD2,046,348,000USD
    Selling General Administrative7,248,510,000USD6,282,807,000USD5,729,156,000USD2,072,862,000USD1,828,736,000USD1,294,138,000USD1,785,196,000USD1,592,041,000USD
    Unclassified Operating Expenses4,325,257,000USD3,569,082,000USD3,183,255,000USD1,573,714,000USD1,426,316,000USD79,134,000USD-103,587,000USD124,794,000USD
    Total Operating Expenses11,573,767,000USD9,851,889,000USD8,912,411,000USD3,646,576,000USD3,255,052,000USD1,373,272,000USD1,681,609,000USD1,716,835,000USD
    Operating Income1,175,381,000USD1,363,094,000USD1,358,354,000USD370,254,000USD321,725,000USD310,596,000USD836,654,000USD329,513,000USD
    Interest Income653,000USD83,672,000USD2,804,000USD—————
    Interest Expense207,246,000USD85,268,000USD109,089,000USD95,547,000USD34,336,000USD64,135,000USD38,233,000USD52,442,000USD
    Net Interest Income-196,972,000USD-83,672,000USD-106,285,000USD—————
    Income Before Tax940,426,000USD1,293,313,000USD1,252,083,000USD275,069,000USD412,472,000USD271,143,000USD317,699,000USD277,071,000USD
    Income Tax Expense221,119,000USD305,681,000USD299,293,000USD104,550,000USD152,878,000USD101,137,000USD118,430,000USD101,710,000USD
    Tax Provision211,584,000USD305,681,000USD299,293,000USD—————
    Net Income717,795,000USD991,590,000USD943,953,000USD170,387,000USD259,458,000USD169,492,000USD199,269,000USD175,361,000USD
    Net Income From Continuing Ops670,054,000USD987,632,000USD952,790,000USD—————
    Ebit1,147,100,000USD1,376,985,000USD1,358,368,000USD327,953,000USD286,754,000USD310,596,000USD836,654,000USD329,513,000USD
    Ebitda1,715,141,000USD1,910,198,000USD1,868,861,000USD511,234,000USD450,448,000USD477,273,000USD981,120,000USD454,307,000USD
    Depreciation And Amortization568,041,000USD533,213,000USD510,493,000USD183,281,000USD163,694,000USD166,677,000USD144,466,000USD124,794,000USD
    Reconciled Depreciation570,913,000USD533,213,000USD510,493,000USD—————
    Total Other Income Expense Net-234,955,000USD-69,781,000USD-106,271,000USD-95,003,000USD135,441,000USD-78,487,000USD-537,335,000USD-52,442,000USD
    Minority Interest6,183,000USD-3,958,000USD8,837,000USD43,361,000USD46,238,000USD20,216,000USD23,280,000USD19,658,000USD
    Net Income Applicable To Common Shares717,487,000USD991,590,000USD943,953,000USD170,519,000USD259,594,000USD169,895,000USD199,241,000USD175,361,000USD
    Non Operating Income Net Other—13,891,000USD14,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets15,935,486,000USD15,681,142,000USD15,957,085,000USD15,343,924,000USD14,985,577,000USD14,875,430,000USD14,469,749,000USD14,353,848,000USD
    Cash And Equivalents138,800,000USD—137,797,000USD112,895,000USD137,595,000USD126,753,000USD125,983,000USD106,077,000USD
    Total Current Assets3,679,325,000USD3,499,701,000USD3,407,915,000USD3,257,962,000USD2,989,982,000USD3,077,374,000USD2,816,288,000USD2,801,956,000USD
    Other Current Assets505,323,000USD406,168,000USD435,574,000USD333,077,000USD327,357,000USD317,106,000USD291,614,000USD261,549,000USD
    Total Liabilities8,280,248,000USD———————
    Total Current Liabilities3,297,656,000USD3,244,078,000USD3,239,601,000USD3,159,190,000USD2,317,071,000USD2,330,252,000USD2,210,406,000USD2,011,188,000USD
    Other Non Current Liabilities559,955,000USD———————
    Total Stockholder Equity7,513,812,000USD7,531,099,000USD7,275,792,000USD7,230,497,000USD7,030,048,000USD6,785,604,000USD6,666,207,000USD6,605,696,000USD
    Total Equity Including Noncontrolling Interest7,655,238,000USD———————
    Short Long Term Debt771,910,000USD756,240,000USD748,158,000USD740,186,000USD40,897,000USD40,410,000USD40,059,000USD38,351,000USD
    Long Term Debt4,079,937,000USD3,952,118,000USD4,004,393,000USD3,950,934,000USD4,542,000,000USD4,609,272,000USD4,464,482,000USD4,618,060,000USD
    Net Receivables2,801,108,000USD2,745,090,000USD2,602,434,000USD2,585,335,000USD2,302,247,000USD2,411,524,000USD2,177,751,000USD2,214,268,000USD
    Property Plant Equipment Net7,508,383,000USD13,985,109,000USD7,382,336,000USD7,355,463,000USD7,272,825,000USD7,106,072,000USD6,990,944,000USD6,864,007,000USD
    Goodwill3,981,713,000USD———————
    Short Term Debt70,861,000USD829,144,000USD821,395,000USD813,520,000USD114,065,000USD116,339,000USD114,708,000USD111,152,000USD
    Total Liab—8,110,043,000USD8,547,677,000USD8,046,445,000USD7,840,495,000USD7,989,696,000USD7,706,933,000USD7,667,139,000USD
    Other Current Liab—58,591,000USD1,400,174,000USD13,252,000USD5,371,000USD2,213,913,000USD1,302,014,000USD-72,801,000USD
    Common Stock—7,464,857,000USD611,000USD7,169,693,000USD637,000USD645,000USD650,000USD662,000USD
    Capital Stock—608,000USD611,000USD624,000USD637,000USD645,000USD650,000USD662,000USD
    Retained Earnings—8,203,077,000USD7,992,755,000USD7,873,558,000USD7,711,745,000USD7,489,409,000USD7,372,061,000USD7,267,348,000USD
    Good Will—3,980,656,000USD3,990,213,000USD3,989,370,000USD3,977,976,000USD3,948,178,000USD3,932,879,000USD3,965,492,000USD
    Cash—119,028,000USD137,797,000USD112,895,000USD137,595,000USD126,753,000USD125,983,000USD106,077,000USD
    Cash And Short Term Investments—119,028,000USD137,797,000USD112,895,000USD137,595,000USD126,753,000USD125,983,000USD106,077,000USD
    Net Debt—5,006,789,000USD5,369,421,000USD4,998,026,000USD4,870,402,000USD4,967,376,000USD4,829,446,000USD5,000,779,000USD
    Short Long Term Debt Total—5,125,817,000USD5,507,218,000USD5,110,921,000USD5,007,997,000USD5,094,129,000USD4,955,429,000USD5,106,856,000USD
    Inventory—229,415,000USD232,110,000USD226,655,000USD222,783,000USD221,991,000USD220,940,000USD220,062,000USD
    Accounts Payable—2,356,343,000USD750,134,000USD2,332,418,000USD2,197,635,000USD2,092,451,000USD632,001,000USD1,896,234,000USD
    Property Plant Equipment Gross—13,985,109,000USD13,864,050,000USD13,831,829,000USD13,627,458,000USD13,314,816,000USD13,062,002,000USD12,869,671,000USD
    Common Stock Shares Outstanding—61,713,628shares64,462,000shares64,991,000shares64,991,000shares66,037,000shares67,074,000shares68,108,000shares
    Non Current Assets Total—12,181,441,000USD12,549,169,999USD12,085,962,000USD11,995,595,000USD11,798,056,000USD11,653,461,000USD11,551,892,000USD
    Non Current Liabilities Total—4,905,965,000USD5,308,075,999USD4,887,255,000USD5,523,424,000USD5,659,444,000USD5,496,527,000USD5,655,951,000USD
    Non Current Liabilities Other—532,678,000USD527,827,000USD589,854,000USD629,492,000USD681,654,000USD655,806,000USD660,247,000USD
    Non Currrent Assets Other—-5,852,663,000USD254,502,999USD595,810,000USD262,881,000USD610,562,000USD611,189,000USD600,489,000USD
    Net Working Capital—255,623,000USD168,314,000USD98,772,000USD672,911,000USD747,122,000USD605,882,000USD790,768,000USD
    Unclassified Non Current Assets—-5,784,324,000USD—-595,810,000USD-262,881,000USD-610,562,000USD-611,189,000USD-600,489,000USD
    Unclassified Current Liabilities—-756,240,000USD-480,260,000USD-740,186,000USD-40,897,000USD-2,132,861,000USD121,624,000USD-34,549,000USD
    Unclassified Non Current Liabilities—421,169,000USD775,855,999USD346,467,000USD351,932,000USD368,518,000USD376,239,000USD377,644,000USD
    Unclassified Equity—-8,137,443,000USD—-7,813,378,000USD-740,720,000USD———
    Intangible Assets——75,875,999USD—————
    Other Assets——747,129,000USD741,129,000USD744,794,000USD743,806,000USD729,638,000USD722,393,000USD
    Accumulated Other Comprehensive Income——-717,574,000USD—57,749,000USD-704,450,000USD-706,504,000USD-662,314,000USD
    Current Deferred Revenue———————-1,896,234,000USD
    Source0001193125-26-340278DeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets15,957,085,000USD14,469,749,000USD13,967,602,000USD13,494,188,000USD13,093,543,000USD13,476,879,000USD11,668,250,000USD11,265,480,000USD
    Intangible Assets75,875,999USD76,273,000USD77,018,000USD78,102,000USD81,041,000USD82,586,000USD83,657,000USD19,732,000USD
    Other Current Assets435,574,000USD291,614,000USD236,658,000USD198,283,000USD194,781,000USD138,034,000USD133,930,000USD174,467,000USD
    Total Liab8,547,677,000USD7,706,933,000USD7,765,696,000USD7,524,143,000USD6,895,371,000USD7,070,343,000USD6,085,046,000USD5,795,395,000USD
    Total Stockholder Equity7,275,792,000USD6,666,207,000USD6,149,001,000USD5,920,582,000USD6,089,664,000USD6,317,146,000USD5,504,105,000USD5,389,262,000USD
    Other Current Liab1,400,174,000USD1,302,014,000USD1,193,666,000USD1,121,590,000USD1,201,590,000USD1,098,148,000USD969,926,000USD937,212,000USD
    Common Stock611,000USD650,000USD672,000USD710,000USD771,000USD851,000USD867,000USD914,000USD
    Capital Stock611,000USD650,000USD672,000USD710,000USD771,000USD851,000USD867,000USD914,000USD
    Retained Earnings7,992,755,000USD7,372,061,000USD6,798,930,000USD5,929,540,000USD6,058,602,000USD6,268,175,000USD5,471,345,000USD5,384,106,000USD
    Good Will3,990,213,000USD3,932,879,000USD3,932,407,000USD3,909,456,000USD3,962,624,000USD3,882,715,000USD3,869,760,000USD3,844,628,000USD
    Other Assets747,129,000USD729,638,000USD665,354,000USD674,284,000USD625,611,000USD602,658,000USD316,430,000USD440,339,000USD
    Cash137,797,000USD125,983,000USD119,439,000USD102,818,000USD115,301,000USD1,224,490,000USD61,268,000USD105,220,000USD
    Cash And Equivalents137,797,000USD125,983,000USD119,439,000USD102,818,000USD115,301,000USD1,224,490,000USD61,268,000USD105,220,000USD
    Cash And Short Term Investments137,797,000USD125,983,000USD119,439,000USD102,818,000USD115,301,000USD1,224,490,000USD61,268,000USD105,220,000USD
    Total Current Assets3,407,915,000USD2,816,288,000USD2,811,350,000USD2,537,340,000USD2,263,556,000USD3,281,869,000USD1,915,934,000USD1,937,802,000USD
    Total Current Liabilities3,239,601,000USD2,210,406,000USD2,013,347,000USD1,914,419,000USD1,984,109,000USD2,481,039,000USD1,563,390,000USD1,448,738,000USD
    Net Debt5,369,421,000USD4,829,446,000USD5,247,189,000USD5,168,460,000USD4,444,095,000USD2,969,860,000USD4,249,377,000USD3,893,413,000USD
    Short Term Debt821,395,000USD114,708,000USD198,286,000USD149,223,000USD112,893,000USD391,794,000USD143,992,000USD63,446,000USD
    Short Long Term Debt748,158,000USD40,059,000USD126,686,000USD81,447,000USD48,409,000USD331,998,000USD87,550,000USD63,446,000USD
    Short Long Term Debt Total5,507,218,000USD4,955,429,000USD5,366,628,000USD5,271,278,000USD4,559,396,000USD4,194,350,000USD4,310,645,000USD3,998,633,000USD
    Long Term Debt4,004,393,000USD4,464,482,000USD4,785,783,000USD4,726,533,000USD4,141,879,000USD3,524,253,000USD3,896,577,000USD3,935,187,000USD
    Net Receivables2,602,434,000USD2,177,751,000USD2,238,265,000USD2,017,722,000USD1,746,635,000USD1,728,928,000USD1,560,847,000USD1,509,909,000USD
    Inventory232,110,000USD220,940,000USD216,988,000USD218,517,000USD206,839,000USD190,417,000USD159,889,000USD148,206,000USD
    Accounts Payable750,134,000USD632,001,000USD613,974,000USD636,601,000USD658,900,000USD570,523,000USD446,957,000USD445,652,000USD
    Property Plant Equipment Net7,382,336,000USD6,990,944,000USD6,558,491,000USD6,373,108,000USD6,241,752,000USD5,709,637,000USD5,343,216,000USD4,847,940,000USD
    Property Plant Equipment Gross13,864,050,000USD13,062,002,000USD12,211,009,000USD11,540,502,000USD10,770,702,000USD5,709,637,000USD5,343,216,000USD4,847,940,000USD
    Accumulated Other Comprehensive Income-717,574,000USD-706,504,000USD-650,601,000USD-9,668,000USD30,291,000USD48,120,000USD31,892,999USD4,242,000USD
    Common Stock Shares Outstanding64,462,000shares67,896,000shares70,125,000shares73,832,000shares83,692,000shares85,587,000shares89,040,000shares93,750,000shares
    Non Current Assets Total12,549,169,999USD11,653,461,000USD11,156,252,000USD10,956,848,000USD10,829,987,000USD10,195,010,000USD9,752,316,000USD9,327,678,000USD
    Non Current Liabilities Total5,308,075,999USD5,496,527,000USD5,752,349,000USD5,609,724,000USD4,911,262,000USD4,589,304,000USD4,521,656,000USD4,346,657,000USD
    Non Current Liabilities Other527,827,000USD655,806,000USD584,007,000USD487,669,000USD464,759,000USD458,549,000USD329,932,000USD361,809,000USD
    Non Currrent Assets Other254,502,999USD216,187,000USD579,728,000USD605,887,000USD579,904,000USD579,969,000USD523,151,000USD629,830,000USD
    Net Working Capital168,314,000USD605,882,000USD798,003,000USD622,921,000USD279,447,000USD800,830,000USD352,544,000USD489,064,000USD
    Unclassified Current Liabilities-480,260,000USD121,624,000USD-124,640,000USD-76,839,000USD-37,689,000USD-287,575,000USD-85,035,000USD-61,018,000USD
    Unclassified Non Current Liabilities775,855,999USD376,239,000USD382,559,000USD-98,411,000USD-166,660,000USD-185,828,000USD-84,927,000USD-411,470,000USD
    Unclassified Non Current Assets—-292,460,000USD-656,746,000USD-683,989,000USD-660,945,000USD-662,555,000USD-523,151,000USD-629,830,000USD
    Current Deferred Revenue——5,375,000USD2,397,000USD6,000USD376,151,000USD—-937,212,000USD
    Deferred Long Term Liab———6,264,000USD6,525,000USD5,582,000USD25,071,000USD49,661,000USD
    Other Liab———487,669,000USD464,759,000USD786,748,000USD355,003,000USD411,470,000USD
    Net Tangible Assets———1,933,024,000USD2,127,040,000USD6,922,635,000USD5,778,514,000USD5,393,554,000USD
    Accumulated Depreciation————-4,896,427,000USD-4,512,764,000USD-4,089,679,000USD-3,715,515,000USD
    Long Term Investments——————139,253,000USD175,039,000USD
    Short Term Investments———————4,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation322,764,000USD
    Stock Based Compensation45,413,000USD
    Change To Account Receivables-137,907,000USD
    Change To Liabilities10,753,000USD
    Change In Working Capital-145,620,000USD
    Operating Cash Flow844,931,000USD
    Capital Expenditures-444,790,000USD
    Other Investing Activities-4,857,000USD
    Unclassified Investing Cash Flow17,835,000USD
    Investing Cash Flow-431,812,000USD
    Net Debt Issuance-203,122,000USD
    Net Common Stock Issuance-484,601,000USD
    Common Dividends Paid-24,760,000USD
    Unclassified Financing Cash Flow301,101,000USD
    Financing Cash Flow-411,382,000USD
    Effect Of Forex Changes On Cash-676,000USD
    Change In Cash1,061,000USD
    End Cash Flow272,383,000USD
    Source0001193125-26-340278DeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income358,678,000USD379,105,000USD362,612,000USD321,628,000USD337,047,000USD258,714,000USD289,147,000USD261,789,000USD
    Depreciation155,426,000USD155,060,000USD152,004,000USD148,345,000USD146,781,000USD149,567,000USD147,480,000USD141,003,000USD
    Stock Based Compensation22,504,000USD24,879,000USD24,112,000USD21,595,000USD26,622,000USD26,565,000USD26,532,000USD19,630,000USD
    Other Non Cash Items-116,841,000USD-78,197,000USD-61,243,000USD-20,705,000USD278,529,000USD8,955,000USD31,715,000USD308,000USD
    Change To Account Receivables-123,862,000USD-201,574,000USD125,738,000USD-218,374,000USD55,652,000USD-54,471,000USD140,620,000USD-74,446,000USD
    Change In Working Capital-122,911,000USD-100,169,000USD71,493,000USD-110,815,000USD-130,542,000USD-110,824,000USD210,939,000USD-26,324,000USD
    Total Cash From Operating Activities401,628,000USD380,678,000USD548,978,000USD360,048,000USD658,437,000USD332,977,000USD679,281,000USD396,406,000USD
    Capital Expenditures-217,157,000USD-247,568,000USD-266,014,000USD-239,026,000USD-245,945,000USD-247,932,000USD-241,394,000USD-208,539,000USD
    Free Cash Flow184,471,000USD133,110,000USD282,964,000USD121,022,000USD412,492,000USD85,045,000USD437,887,000USD187,867,000USD
    Investments14,716,000USD-269,413,000USD-305,939,000USD-271,299,000USD-207,993,000USD-265,637,000USD-242,842,000USD-194,637,000USD
    Total Cashflows From Investing Activities-197,579,000USD-269,413,000USD-305,939,000USD-271,299,000USD-207,993,000USD-265,637,000USD-242,842,000USD-194,637,000USD
    Net Borrowings-44,691,000USD105,142,000USD-67,288,000USD143,341,000USD-168,486,000USD109,370,000USD——
    Total Cash From Financing Activities-221,894,000USD-134,521,000USD-227,651,000USD-91,420,000USD-426,760,000USD-89,650,000USD-419,520,000USD-208,947,000USD
    Dividends Paid-12,974,000USD-12,468,000USD-12,900,000USD-13,534,000USD-13,044,000USD-13,296,000USD-13,405,000USD-13,601,000USD
    Sale Purchase Of Stock-163,849,000USD-237,399,000USD-155,157,000USD-223,385,000USD-250,166,000USD-182,601,000USD-95,903,000USD-142,084,000USD
    Issuance Of Capital Stock3,782,000USD3,982,000USD4,479,000USD3,658,000USD4,206,000USD3,637,000USD3,986,000USD3,241,000USD
    Change In Cash-18,769,000USD-24,797,000USD17,674,000USD-1,026,000USD20,155,000USD-19,222,000USD17,019,000USD-7,670,000USD
    Begin Period Cash Flow271,322,000USD241,400,000USD223,726,000USD224,752,000USD204,597,000USD223,819,000USD112,093,000USD214,470,000USD
    End Period Cash Flow252,553,000USD216,603,000USD241,400,000USD223,726,000USD224,752,000USD204,597,000USD128,786,000USD206,800,000USD
    Other Cashflows From Investing Activities14,744,000USD17,513,000USD-40,189,000USD-23,695,000USD43,422,000USD-10,876,000USD-1,489,000USD155,000USD
    Other Cashflows From Financing Activities-4,162,000USD6,222,000USD3,215,000USD-1,500,000USD3,304,000USD-6,760,000USD4,572,000USD-4,636,000USD
    Unclassified Operating Cash Flow104,772,000USD—————-26,532,000USD—
    Unclassified Investing Cash Flow-9,882,000USD230,055,000USD306,203,000USD262,721,000USD202,523,000USD258,808,000USD242,883,000USD208,384,000USD
    Unclassified Financing Cash Flow3,782,000USD3,982,000USD4,479,000USD3,658,000USD—3,637,000USD-314,784,000USD-48,626,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income1,511,182,000USD1,163,109,000USD717,487,000USD656,982,000USD987,632,000USD952,790,000USD827,543,000USD797,883,000USD
    Depreciation618,743,000USD584,831,000USD568,041,000USD581,861,000USD533,213,000USD510,493,000USD490,392,000USD453,076,000USD
    Stock Based Compensation95,688,000USD99,349,000USD87,720,000USD85,378,000USD73,686,000USD65,837,000USD69,431,000USD66,581,000USD
    Other Non Cash Items-85,323,000USD-198,947,000USD-124,339,000USD-83,849,000USD-790,264,000USD-113,085,000USD-97,781,000USD-76,147,000USD
    Change To Account Receivables-317,985,000USD67,355,000USD-182,444,000USD-258,338,000USD-8,873,000USD-145,901,000USD-42,056,000USD-42,239,000USD
    Change In Working Capital-275,893,000USD418,759,000USD17,068,000USD-244,349,000USD53,376,000USD940,812,000USD58,793,000USD49,976,000USD
    Total Cash From Operating Activities1,864,397,000USD2,067,101,000USD1,267,797,000USD996,023,000USD883,695,000USD2,360,169,000USD1,438,469,000USD1,340,893,000USD
    Capital Expenditures-1,015,152,000USD-943,810,000USD-743,055,000USD-734,001,000USD-855,659,000USD-734,209,000USD-663,518,000USD-811,669,000USD
    Free Cash Flow849,245,000USD1,123,291,000USD524,742,000USD262,022,000USD28,036,000USD1,625,960,000USD774,951,000USD529,224,000USD
    Investments1,029,000USD-911,109,000USD-763,275,000USD-647,296,000USD1,357,000USD-24,412,000USD-34,342,000USD-15,331,000USD
    Total Cashflows From Investing Activities-1,070,617,000USD-911,109,000USD-763,275,000USD-647,296,000USD-914,466,000USD-802,562,000USD-688,410,000USD-813,398,000USD
    Net Borrowings242,032,000USD-429,753,000USD99,620,000USD615,954,000USD217,106,000USD-171,268,000USD-17,922,000USD-53,036,000USD
    Total Cash From Financing Activities-749,727,000USD-1,144,877,000USD-493,945,000USD-318,400,000USD-1,068,950,000USD-384,859,000USD-845,036,000USD-492,202,000USD
    Dividends Paid-51,267,000USD-53,346,000USD-55,480,000USD-58,449,000USD-65,896,000USD-17,344,000USD-53,003,000USD-37,342,000USD
    Sale Purchase Of Stock-967,951,000USD-670,754,000USD-547,363,000USD-832,918,000USD-1,220,875,000USD-206,719,000USD-770,504,000USD-397,425,000USD
    Issuance Of Capital Stock16,729,000USD15,070,000USD13,654,000USD14,068,000USD13,372,000USD12,318,000USD10,806,000USD10,196,000USD
    Change In Cash46,570,000USD10,282,000USD13,633,000USD21,903,000USD-1,100,220,000USD1,173,487,000USD-94,018,000USD32,388,000USD
    Begin Period Cash Flow224,752,000USD214,470,000USD200,837,000USD178,934,000USD1,279,154,000USD105,667,000USD199,685,000USD167,297,000USD
    End Period Cash Flow271,322,000USD224,752,000USD214,470,000USD200,837,000USD178,934,000USD1,279,154,000USD105,667,000USD199,685,000USD
    Other Cashflows From Investing Activities28,689,000USD51,423,000USD-16,508,000USD86,705,000USD1,457,000USD-46,843,000USD-19,973,000USD13,502,000USD
    Other Cashflows From Financing Activities11,112,000USD-6,094,000USD-4,376,000USD648,266,000USD3,242,317,000USD789,453,000USD24,807,000USD-14,595,000USD
    Unclassified Investing Cash Flow-85,183,000USD892,387,000USD759,563,000USD647,296,000USD-61,621,000USD—29,423,000USD—
    Unclassified Financing Cash Flow16,347,000USD15,070,000USD13,654,000USD-691,253,000USD-3,241,602,000USD-778,981,000USD-28,414,000USD10,196,000USD
    Change To Liabilities———0USD104,140,000USD268,390,000USD113,375,000USD157,478,000USD
    Cash And Cash Equivalents Changes————-1,099,721,000USD1,172,748,000USD-94,977,000USD35,293,000USD
    Unclassified Operating Cash Flow————26,052,000USD—90,091,000USD49,524,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductInvestment Advice1,400,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductManaged Care1,202,141,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductManaged Medicaid653,738,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductManaged Medicare548,673,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductMedicaid820,202,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductMedicare478,705,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductOther Non Patient Revenue354,641,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductOther Patient Revenue And Adjustments Net310,708,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30ProductUKRevenue269,204,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30SegmentAcute Care Hospital Services2,609,999,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30SegmentAll Other Segments2,948,000USD0001193125-26-340278
    Q2 2026Quarterly · 2026-06-30SegmentBehavioral Health Services2,025,065,000USD0001193125-26-340278
    Q1 2026Quarterly · 2026-03-31ProductInvestment Advice1,400,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductManaged Care1,200,498,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductManaged Medicaid646,602,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductManaged Medicare550,100,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductMedicaid709,900,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductMedicare481,677,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductOther Non Patient Revenue315,849,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductOther Patient Revenue And Adjustments Net329,344,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31ProductUKRevenue261,212,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31SegmentAcute Care Hospital Services2,610,136,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31SegmentAll Other Segments2,894,000USD0001193125-26-211992
    Q1 2026Quarterly · 2026-03-31SegmentBehavioral Health Services1,882,152,000USD0001193125-26-211992
    Q4 2025Quarterly · 2025-12-31ProductInvestment Advice1,400,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductManaged Care1,247,621,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductManaged Medicaid632,232,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductManaged Medicare524,196,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicaid749,674,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare478,535,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductOther Non Patient Revenue289,758,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductOther Patient Revenue And Adjustments Net301,136,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductUKRevenue262,896,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentAcute Care Hospital Services2,536,994,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentAll Other Segments2,953,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentBehavioral Health Services1,946,101,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductInvestment Advice5,600,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductManaged Care4,902,096,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductManaged Medicaid2,482,601,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductManaged Medicare2,080,278,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductMedicaid2,686,967,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductMedicare1,856,404,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductOther Non Patient Revenue1,114,849,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductOther Patient Revenue And Adjustments Net1,240,278,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31ProductUKRevenue1,001,356,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31SegmentAcute Care Hospital Services9,925,907,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31SegmentAll Other Segments13,422,000USD0001193125-26-071676
    FY 2025Yearly · 2025-12-31SegmentBehavioral Health Services7,425,500,000USD0001193125-26-071676
    Q3 2025Quarterly · 2025-09-30ProductInvestment Advice1,400,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductManaged Care1,241,821,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductManaged Medicaid627,932,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductManaged Medicare516,611,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductMedicaid766,265,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductMedicare460,583,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductOther Non Patient Revenue298,532,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductOther Patient Revenue And Adjustments Net319,015,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30ProductUKRevenue264,486,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30SegmentAcute Care Hospital Services2,630,065,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30SegmentAll Other Segments4,921,000USD0001193125-25-272385
    Q3 2025Quarterly · 2025-09-30SegmentBehavioral Health Services1,860,259,000USD0001193125-25-272385
    Q2 2025Quarterly · 2025-06-30ProductInvestment Advice1,400,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductManaged Care1,227,853,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductManaged Medicaid619,608,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductManaged Medicare519,172,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductMedicaid644,120,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductMedicare449,247,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductOther Non Patient Revenue266,856,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductOther Patient Revenue And Adjustments Net310,054,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30ProductUKRevenue246,906,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30SegmentAcute Care Hospital Services2,401,034,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30SegmentAll Other Segments2,706,000USD0000950170-25-105857
    Q2 2025Quarterly · 2025-06-30SegmentBehavioral Health Services1,880,076,000USD0000950170-25-105857
    Q1 2025Quarterly · 2025-03-31ProductInvestment Advice1,400,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductManaged Care1,184,801,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductManaged Medicaid602,829,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductManaged Medicare520,299,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductMedicaid526,908,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductMedicare468,039,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductOther Non Patient Revenue259,703,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductOther Patient Revenue And Adjustments Net310,073,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31ProductUKRevenue227,068,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31SegmentAcute Care Hospital Services2,357,814,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31SegmentAll Other Segments2,842,000USD0001193125-26-211992
    Q1 2025Quarterly · 2025-03-31SegmentBehavioral Health Services1,739,064,000USD0001193125-26-211992
    Q4 2024Quarterly · 2024-12-31ProductInvestment Advice1,400,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductManaged Care1,140,229,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductManaged Medicaid574,949,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductManaged Medicare472,024,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicaid676,478,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare425,200,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOther Non Patient Revenue307,311,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOther Patient Revenue And Adjustments Net288,038,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductUKRevenue229,493,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentAcute Care Hospital Services2,326,702,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentAll Other Segments2,641,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentBehavioral Health Services1,784,379,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductInvestment Advice5,500,000USD0001193125-26-071676
    FY 2024Yearly · 2024-12-31ProductManaged Care4,496,402,000USD0001193125-26-071676
    FY 2024Yearly · 2024-12-31ProductManaged Medicaid2,303,938,000USD0001193125-26-071676
    FY 2024Yearly · 2024-12-31ProductManaged Medicare1,883,905,000USD0001193125-26-071676

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.